Vericel Corporation - Common Stock (NQ:VCEL)

40.15 +0.71 (+1.80%)

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Vericel Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

HC Wainwright & Co. Maintains Buy Rating for Vericel: Here's What You Need To Know ↗

January 16, 2024

Via Benzinga

Vericel Announces Preliminary Full-Year and Fourth Quarter 2023 Financial Results

January 09, 2024

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024

January 03, 2024

From Vericel Corporation

Via GlobeNewswire

Innovative Burn Care: MediWound Bags Additional DoD Grant For NexoBrid Development ↗

December 28, 2023

Biopharmaceutical company MediWound Ltd (NASDAQ: MDWD) reported that the U.S.

Via Benzinga

3 Biotech Stocks That Could Boom or Bust by 2025 ↗

November 16, 2023

Biotech stocks are popular with investors because they sometimes provide tremendous rewards. Here are three to buy for a potential payday.

Via InvestorPlace

Analyst Ratings for Vericel ↗

October 16, 2023

Via Benzinga

Analyst Ratings for Vericel ↗

September 21, 2023

Via Benzinga

Expert Ratings for Vericel ↗

August 03, 2023

Via Benzinga

3 Strong Buy Stocks Set to Take Off in the Coming Months ↗

November 10, 2023

These 3 strong buy stocks have industry experts' positive outlook and seal of approval. The only question is, are you in?

Via InvestorPlace

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

November 08, 2023

From Vericel Corporation

Via GlobeNewswire

Earnings Scheduled For November 8, 2023 ↗

November 08, 2023

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.

Via Benzinga

Vericel: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Vericel Earnings Perspective: Return On Capital Employed ↗

February 28, 2023

Via Benzinga

Vericel to Present at the Stephens Annual Investment Conference

November 07, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

October 25, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

September 28, 2023

From Vericel Corporation

Via GlobeNewswire

Analyst Expectations for Vericel's Future ↗

February 27, 2023

Via Benzinga

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

September 20, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel's Short Report: Deep Dive Into Knee-Repair Focused Company's 27 Years of Losses ↗

September 20, 2023

J Capital Research has released a short idea report on Vericel Corporation (NASDAQ:

Via Benzinga

Vericel to Present at the Morgan Stanley Global Healthcare Conference

September 06, 2023

From Vericel Corporation

Via GlobeNewswire

As America Grapples With A Deadly Opioid Epidemic, BioRestorative Therapies Is Looking To Treat Chronic Pain Without The Need For Class-A Drugs ↗

August 29, 2023

Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to experts, up to 80% of the population will experience back pain at some point.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023 ↗

August 08, 2023

Via Benzinga

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

August 02, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

July 20, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel Corp. (NASDAQ: VCEL) Sets New 52-Week High in Tuesday Session

May 23, 2023

Via Investor Brand Network

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

May 10, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

April 26, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

February 28, 2023

From Vericel Corporation

Via GlobeNewswire

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

February 23, 2023

From Vericel Corporation

Via GlobeNewswire

Earnings Scheduled For February 23, 2023 ↗

February 23, 2023

Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.